mitomycin has been researched along with fosbretabulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Liang, Y; Lin, S; Pan, F; Wang, Y | 1 |
| Przybylski, P; Łowicki, D | 1 |
1 review(s) available for mitomycin and fosbretabulin
| Article | Year |
|---|---|
Cascade synthetic strategies opening access to medicinal-relevant aliphatic 3- and 4-membered N-heterocyclic scaffolds.
Topics: Bridged Bicyclo Compounds; Nitrogen | 2022 |
1 other study(ies) available for mitomycin and fosbretabulin
| Article | Year |
|---|---|
Novel diaryl-2H-azirines: Antitumor hybrids for dual-targeting tubulin and DNA.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azirines; Cell Line, Tumor; Cell Proliferation; DNA; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Polymerization; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2021 |